Side-effects associated with ketamine use in depression: a systematic review

B Short, J Fong, V Galvez, W Shelker… - The Lancet Psychiatry, 2018 - thelancet.com
This is the first systematic review of the safety of ketamine in the treatment of depression
after single and repeated doses. We searched MEDLINE, PubMed, PsycINFO, and …

Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the …

SP Cohen, A Bhatia, A Buvanendran… - Regional Anesthesia & …, 2018 - rapm.bmj.com
Background Over the past 2 decades, the use of intravenous ketamine infusions as a
treatment for chronic pain has increased dramatically, with wide variation in patient …

A consensus statement on the use of ketamine in the treatment of mood disorders

G Sanacora, MA Frye, W McDonald, SJ Mathew… - JAMA …, 2017 - jamanetwork.com
Importance Several studies now provide evidence of ketamine hydrochloride's ability to
produce rapid and robust antidepressant effects in patients with mood and anxiety disorders …

Ketamine: NMDA receptors and beyond

CF Zorumski, Y Izumi, S Mennerick - Journal of Neuroscience, 2016 - Soc Neuroscience
Human studies examining the effects of the dissociative anesthetic ketamine as a model for
psychosis and as a rapidly acting antidepressant have spurred great interest in …

[HTML][HTML] Pharmacological treatments for patients with treatment-resistant depression

VL Ruberto, MK Jha, JW Murrough - Pharmaceuticals, 2020 - mdpi.com
Over a third of patients with major depressive disorder (MDD) do not have an adequate
response to first-line antidepressant treatments, ie, they have treatment-resistant depression …

Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis

GC Medeiros, TD Gould, WL Prueitt, J Nanavati… - Molecular …, 2022 - nature.com
Abstract (R, S)-ketamine (ketamine) and its enantiomer (S)-ketamine (esketamine) can
produce rapid and substantial antidepressant effects. However, individual response to …

[HTML][HTML] Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression

JS Siegel, BJA Palanca, BM Ances, ED Kharasch… - …, 2021 - Springer
Ketamine produces a rapid antidepressant response in over 50% of adults with treatment-
resistant depression. A long infusion of ketamine may provide durable remission of …

Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression

Y Zhou, W Zheng, W Liu, C Wang… - Journal of …, 2018 - journals.sagepub.com
Background: Ketamine has proven to have rapid, robust antidepressant effects on treatment-
resistant depression. However, whether repeated ketamine infusions would cause short-and …

[HTML][HTML] Strategies to prolong ketamine's efficacy in adults with treatment-resistant depression

EP McMullen, Y Lee, O Lipsitz, LMW Lui, M Vinberg… - Advances in …, 2021 - Springer
Introduction Ketamine treatment is capable of significant and rapid symptom improvement in
adults with treatment-resistant depression (TRD). A limitation of ketamine treatment in TRD …

Factors influencing the cardiovascular response to subanesthetic ketamine: a randomized, placebo-controlled trial

T Liebe, S Li, A Lord, L Colic, AL Krause… - International Journal …, 2017 - academic.oup.com
Background The increasing use of ketamine as a potential rapid-onset antidepressant
necessitates a better understanding of its effects on blood pressure and heart rate, well …